Nakagawa, Y., Abram, V., Kezdy, F.J., Kaiser, E.T. and Coe, F.L. (1983) Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. The Journal of Biological Chemistry, 258, 12594-12600.
 Atmani, F., Mizon, J. and Khan, S. R. (1996) Identi- fication of uronic acid rich protein as urinary bikunin, the light chain of inter-a-inhibitor. European Journal of Biology Chemistry, 236, 984.
 Wesson, J.A., Johnson, R.J. and Mazzali, M.A, et al. (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. Journal of the American Society Nephrology, 14, 139-147.
 Taller, A., Grohe, B., Rogers, K.A., Goldberg, H.A. and Hunter, G.K. (2007) Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohy- drate crystals. Biophysical Journal, 93, 1768-1777.
 Sorensen, E.S., Hojrup, P. and Petersen, T.E. (1995) Post-translational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-gly- cosylation sites. Protein Scienty, 4, 2040-2049.
 Christensen, B., Nielsen, M.S., Haselmann, K.F., Petersen, T.E. and Sorensen, E.S. (2005) Posttranslationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochemical Journal, 390, 285-292.
 Lian, J.B., Prien, E.L., Glimcher, M.J. and Gallop, P.M. (1977) The presence of protein bound ccarboxyglutamic acid in calcium-containing renal calculi. Journal of Clinicine Investigation, 59, 1151.
 Priyadarshini, Singh, S.K. and Tandon, C. (2009) Mass spectrometric identification of human phosphate cytidy- lyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix. Clinica Chimica Acta, 408, 34-38.
 Lee, J., Johnson, J., Ding, Z., Paetzel, M. and Cornell, R.B. (2009) Crystal structure of a mammalian CTP: phosphocholine cytidylyltransferase catalytic domain reveals novel active site residues within a highly conserved nucleotidyltransferase fold. The Journal of Biological Chemistry, 284, 33535-33548.
 Jon, A.F., Heidi, A.C. and Claudia Kent. (1999) Enzymatic and cellular characterization of a catalytic fragment of CTP: Phosphocholine Cytidylyltransferase α. The Journal of Biological Chemistry, 274, 13384-13389.
 Aggarwal, S., Tandon, C., Forouzandeh, M., Singla, S.K., Kiran, R. and Jethi, R.K. (2000) Role of biomolecules from human renal stone matrix on COM crystal growth. Molecular and Cellular Biochemistry, 210, 109-119.
 Shirane, Y., Kurokawa, Y., Miyashita, S., Komatsu, H. and Kagawa, S. (1999) Study of inhibition mechanisms of glycosaminoglycans on calcium oxalate monohydrate crystals byatomic force microscopy. Urology Research, 27, 426-431.
 Guo, S., Ward, M.D. and Wesson, J.A. (2002) Direct visualization of calcium oxalate monohydrate (COM) crystallization and dissolution with atomic force microscopy (AFM) and the role of polymeric additives. Langmuir, 18, 4284-4291.
 Qiu, S.R., Wierzbicki, A. and Orme, C.A. et al. (2004) Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proceedingof the Natlional Academy Science of the USA, 101, 1811-1815.
 Jung, T., Sheng, X., Choi, C.K., Kim, W., Wesson, J.A. and Ward, M.D. (2004) Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir, 20, 8587-8596.
 Bijarnia, R.K., Kaur, T., Naik, P.K., Singla, S.K. and Tandon C. (2008) In silico study on interaction of active binding sites of proteins with calcium oxalate monohydrate. Office of James Bumett, 2, 92-107.
 Tandon, C., Aggarwal, S., Forouzandeh, M. and Jethi, R.K. (1998) Inhibitors of in vitro mineralization from rabbit aorta and their role in biomineralization. Journal of Cellular Biochemistry, 68, 287-297.
 Nakagawa, Y., Ahmed, M., Hall, S.L., Deganello, S. and Coe F.L. (1987) Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephr- ocalcin from patients with calcium oxalate nephr- olithiasis is deficient in γ-carboxyglutamic acid. Journal of Clinical Investigation, 79, 1782-1787.
 Nakagawa, Y., Abram, V., Parks, J.H., Lau, H.S.H., Kawooya, J.K. and Coe, F.L. (1985) Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. Journal of Clinical Investigation, 76, 1455-1462.
 Shiraga, H., Min, W., VanDusen, W.J. et al. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid rich protein superfamily. Proceedingof the Natlional Academy Science of the USA, 89, 426-430.
 Kalmar, G.B., Kay, R.J., Lachance, A., Aebersold, R. and Cornell, R.B. (1990) Cloning and expression of rat liver CTP: phosphocholine cytidylyltransferase: an amphi- pathic protein that controls phosphatidylcholine synthesis. Proceedingof the Natlional Academy Science of the USA, 87, 6029-6033.
 Kaur, T., Bijarnia, R.K., Singla, S.K. and Tandon, C. (2009) Purification and characterization of an anticalcifying protein from the seeds of Trachyspermum ammi (L.). Protein and Peptides Letters, 16, 173-81.